FoRx Therapeutics Company
FoRx Therapeutics is a recently incorporated privately-held company aiming to develop first-in-class compounds for cancer treatment.
FoRx focuses on drugging key molecular targets involved in DNA replication stress, as a new approach towards the development of targeted anticancer drugs.
Investors
Connections
Headquarters:
Basel, Basel-Stadt, Switzerland, Europe
Founded Date:
2019-10-01
Industry:
Drug Discovery & Development
Employee Number:
11-50
Super Industry:
Biopharma & Life Science Tools
Investors:
EQT Life Sciences, M Ventures, Omega Funds, Pfizer, Pfizer Venture Investments
Ipo Status:
private
City:
Basel
Region:
Basel-Stadt
Country:
Switzerland
Founders:
Sotirios Sotiriou, Thanos Halazonetis